Made of Genes uses artificial intelligence, data science and systems biology to integrate biomarkers such as blood tests and DNA to deliver personalized health and wellbeing recommendations. The company originated as a spin-off of Genomcore and is staffed by around thirty healthcare professionals, biologists and engineers. It is expanding its Made of Genes ONE study to combine blood and DNA analyses with external athlete data — body parameters and biosensor metrics like sleep quality, muscle loads and injury records — for services to FC Barcelona. Made of Genes and Barça Innovation Hub plan to co-create pioneering AI algorithms for high‑performance athletes that explicitly incorporate a gender perspective to address the needs of female athletes. The platform aims to optimize performance, personalize training and recovery, predict injury risk and complement teams' guidance on nutrition and emotional wellbeing. Financially, the company announced investment from Barça Innovation Hub and recently closed a €2.4M funding round led by FCV Equity with participation from Scale Lab Andorra, Break Off Capital and Capital Cell. Made of Genes (the personalized-health brand of Genomcore S.L.) offers integrated health studies that combine genetic, serological (including IgG antibody tests) and biochemical/metabolic markers to deliver a comprehensive view of an individual’s health. The company has positioned its services to go beyond static genetic reports by adding a dynamic assessment of current health status and comorbidity risk, including a COVID-19–focused product called #REACTIVATE. #REACTIVATE is marketed as an affordable test (under €100) that identifies past infection, antibody response, and risk of severe respiratory complications. The newly closed financing will be used to scale the company’s VITAL and HEALTH service lines and to improve go-to-market execution. Made of Genes highlights data custody and reuse practices (including Blockchain-based privacy and consent management) as part of its innovation profile. The company was founded in January 2015 and has received recognition such as MIT Technology Review’s Innovators Under 35 and other international awards. Made of Genes operates a marketplace that sequences clients' genes, digitizes their genomes and hosts them in the cloud so customers can grant access to partnered healthcare professionals. The service monetizes via commissions when a client pays a professional to analyze their genome. The company was founded by Dr. Óscar Flores and consultant Miquel Bru and has secured commitments from 10 healthcare companies and integration with 150 disease‑detection apps. Made of Genes plans to generate €50,000 in revenue in its first year and expected to grow to 20 employees by 2017. The startup is based in Barcelona.

Total raised

$3M

Funding rounds

3

Latest round

Equity

Latest activity

Jul 2020